E. Kubista
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Co-authors
- K. Czerwenka (71 shared papers)R. Jakesz (36 shared papers)Christian F. Singer (50 shared papers)Gernot Hudelist (51 shared papers)Michael Gnant (31 shared papers)H. Hausmaninger (18 shared papers)Hellmut Samonigg (11 shared papers)W. Kwasny (12 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)European Journal of Cancer (11 papers)Breast Cancer Research and Treatment (11 papers)Gynecologic Oncology (7 papers)Cancer Research (6 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
E. Kubista
230 papers receiving 6.6k citations
E. Kubista's Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.9k
- Oncology 3.0k
- Genetics 1.2k
- Reproductive Medicine 267
- Pathology and Forensic Medicine 445
Countries citing papers authored by E. Kubista
This map shows the geographic impact of E. Kubista's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Kubista with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Kubista more than expected).
Fields of papers citing papers by E. Kubista
This network shows the impact of papers produced by E. Kubista. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Kubista. The network helps show where E. Kubista may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Kubista, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer Hit paper breakdown → | 2009 | 504 |
| 2 | Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. | 2002 | 332 |
| 3 | 2008 | 282 | |
| 4 | 2004 | 236 | |
| 5 | 2007 | 215 | |
| 6 | 2009 | 209 | |
| 7 | 2004 | 203 | |
| 8 | 2002 | 200 | |
| 9 | 2001 | 189 | |
| 10 | 2011 | 171 | |
| 11 | 2004 | 161 | |
| 12 | Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. | 2001 | 160 |
| 13 | HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. | 1989 | 131 |
| 14 | 2002 | 112 | |
| 15 | 2005 | 101 | |
| 16 | 2005 | 90 | |
| 17 | 1994 | 86 | |
| 18 | 2008 | 79 | |
| 19 | 2003 | 77 | |
| 20 | 2000 | 75 |
About E. Kubista
E. Kubista is a scholar working on Oncology, Genetics, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 246 papers that have together received 6.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (37 papers), Estrogen and related hormone effects (36 papers), HER2/EGFR in Cancer Research (33 papers), Cancer Treatment and Pharmacology (19 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Cancer Cells and Metastasis (11 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Risks and Factors (11 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (3.0k citations), Genetics (1.2k citations), Reproductive Medicine (267 citations) and Pathology and Forensic Medicine (445 citations). E. Kubista has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include K. Czerwenka, R. Jakesz, Christian F. Singer, Gernot Hudelist, Michael Gnant, H. Hausmaninger, Hellmut Samonigg, W. Kwasny, M. Manavi and Michael Seifert. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research and Treatment, Gynecologic Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.